Chi Sheng Pharma & Biotech Co., Ltd

NT$28.20As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4111Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 6.60%
Div yield 4.61%
ROE 13.40%
Medical Instruments & Supplies
Beta (5Y) 0.20
PE TTM 9.189
TSR TTM (3.04%)
Mkt cap NT$1.687B
ROIC 15.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$35
25.19%
(55.39%)
Hold 9|7|8|5|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.31
0.32
0.34
0.35
5.50%
(0.27%)
10.92%
10.11%
RevenueNT$M
82.86
84.55
86.33
91.39
11.99%
10.33%
11.54%
14.45%
Peers (US$50.96M)
Cap (US$)
PE
55.19M
12.16x
Capital
TTM
5Y
10Y
Leveragex
0.529
0.769
0.599
EBIT/Intx
0.826
2.501
2.008
Own earn%
158.62
(165.63)
(161.12)
Sh yield%
56.96
38.92
38.77
Owners
Insiders/Inst%
7.56
74.91
Short interest%
5.50
SBC / revenue%
2.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
22